Alkermes plc announced the appointment of Craig Hopkinson, M.D., as Chief Medical Officer, and Senior Vice President of Clinical Development and Medical Affairs. Dr. Hopkinson will be responsible for the advancement and implementation of the clinical development programs for Alkermes’ pipeline of drug candidates. He will serve on the executive management team of Alkermes and report to Elliot Ehrich, M.D., Executive Vice President of Research and Development. Dr. Ehrich will transition his role as Chief Medical Officer to Dr. Hopkinson and will focus on advancing the company’s product pipeline and pharmaceutical development strategy.